Single branch heparin-binding growth factor analogs

Details for Australian Patent Application No. 2006216676 (hide)

Owner Biosurface Engineering Technologies, Inc.

Inventors Zamora, Paul O.; Takahashi, Kazuyuki

Agent Callinan

Pub. Number AU-A-2006216676

PCT Pub. Number WO2006/091727

Priority 11/359,173 21.02.06 US; 60/655,570 22.02.05 US

Filing date 22 February 2006

Wipo publication date 31 August 2006

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/091727 Priority application(s): WO2006/091727

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216678-Revascularization of ischemic retinal tissue and screening method therefor

2006216671-Alkyl-glycoside enhanced vaccination